Skip to main content
. Author manuscript; available in PMC: 2016 Apr 28.
Published in final edited form as: Radiother Oncol. 2016 Jan 9;118(1):85–91. doi: 10.1016/j.radonc.2015.11.035

Table 3.

Differences between groups at 4 years.a

Domain Radical prostatectomy vs. brachytherapy Radical prostatectomy vs. IMRT Radical prostatectomy vs. Androgen deprivationb

Delta (95% CI) P Delta (95% CI) P Delta (95% CI) P
Urinary unction .83 (−1.59, 3.26) .5 1.06 (−1.64, 3.75) .4 −1.53 (−6.45, 3.39) .5
 Incontinence 10.13 (6.27, 13.98) <.001 11.03 (6.70, 15.37) <0.001 7.30 (−1.11, 15.72) .089
 Irritation or obstruction −6·36 (−8·55, −4·16) <0·001 −6·83 (−9·28, −4·38) <0·001 −8·30 (−12·17, −4·43) <0·001
Urinary bother −.18 (−3.00, 2.63) .9 1.17 (−1.96, 4.31) .5 −1.82 (−7.61, 3.96) .5
Bowel function −1.08 (−2.46, .31) .13 −1.30 (−2.81, .20) .090 −.00 (−2.52, 2.52) 1
 Pain or constipation .89 (−1.15, 2.92) .4 1.48 (−.92, 3.87) .2 2.44 (−1.95, 6.82) .3
 Diarrhea or frequency −1.26 (−3.08, .56) .2 −0·78 (−2·83, 1·28) .5 1.11 (−2.36, 4.59) .5
 Rectal bleeding −1.39 (−3.51, .73) .2 −4.80 (−7.59, −2.01) .001 −3.97 (−7.92, −.01) .049
Bowel bother −1.97 (−4.58, .64) .14 −2.65 (−5.52, .22) .071 −3.02 (−7.32, 1.28) .2
Sexual function 14.29 (8.57, 20.01) <.001 10.55 (3.78, 17.33) .002 11.30 (−0.55, 23.15) .061
 Sexual desire 10.30 (5.61, 14.99) <.001 4.27 (−1.37, 9.90) .14 5.89 (−3.95, 15.73) .2
 Erectile unction 16.51 (9.43, 23.60) <.001 14.99 (6.75, 23.23) <.001 15.51 (1.06, 29.95) .035
Sexual bother 8.40 (3.50, 13.31) .001 7.29 (1.89, 12.68) .008 8.35 (−1.48, 18.19) .10
 Intercourse bother 7.44 (2.48, 12.41) 003 6.53 (1.19, 11.88) .017 8.76 (−1.02, 18.55) .079
 Intercourse satisfaction 11.69 (4.10, 19.28) .003 10.08 (1.21, 18.95) .026 10.59 (−4.87, 26.04) .2

Abbreviations: CI = confidence interval, IMRT = intensity-modulated radiotherapy.

a

Difference between means (delta) for scores at 48 months in each domain and subdomain for the treatments specified, with 95% confidence intervals in parentheses. Radical prostatectomy (open or laparoscopic) is the reference group in all comparisons. A positive score means better function in radiotherapy compared with surgery.

b

The androgen-deprivation group includes radiotherapy patients (external beam or brachytherapy) who also received adjuvant or neoadjuvant hormones of any duration. Patients undergoing radiotherapy plus hormonal therapy are thus represented in both columns.